巨噬细胞
甘露糖受体
纳米载体
促炎细胞因子
肺
免疫学
吞噬作用
受体
肺泡巨噬细胞
免疫系统
先天免疫系统
医学
药品
抗原呈递
药理学
炎症
细胞生物学
生物
体外
T细胞
生物化学
内科学
作者
Ana Costa,Bruno Sarmento,Vítor Seabra
标识
DOI:10.2174/1389450115666141114152713
摘要
Lung macrophages present an effective role in innate and immune response through specific and non-specific mechanisms, namely phagocytosis, antigen processing and presentation through major histocompatibility complex, activation of T cells and inflammatory cytokines release. Despite their protective role against injury in normal condition, they can cause several lung conditions, since they can mediate several processes, through recruitment of other inflammatory cells for alveolar space, release of proinflammatory cytokines or stimulation of collagen deposition. Lung macrophages constitute a good therapeutic target. With the development of nanotechnology, new carriers have been designed to target drugs towards these cells. One of the commonly used approaches is the attachment of ligands with affinity to receptors presented at lung macrophage surface, to the nanocarriers. This review will focus on the importance of lung macrophages in host-defense, their influence on different pulmonary diseases and different strategies for alveolar macrophage targeting. Keywords: Alveolar macrophages, drug delivery systems, ligands, macrophages receptors, mannose receptors, targeting.
科研通智能强力驱动
Strongly Powered by AbleSci AI